✦ LIBER ✦

Outcome of discontinuing bevacizumab prior to malignant glioma progression

✍ Scribed by Wendy J. Sherman, Jeffrey J. Raizer, Sean A. Grimm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of salvage reirradiation for ma

✍ Roy G. Torcuator; Ravneet Thind; Mehul Patel; Y. S. Mohan; Joseph Anderson; Thom 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 344 KB

Bevacizumab plus irinotecan in recurrent

✍ Umut Demirci, Gulnihal Tufan, Bilge Aktas… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 249 KB

Early prognostic factors related to prog

✍ Tae-Young Jung; Shin Jung; Jung-Ho Moon; In-Young Kim; Kyung-Sub Moon; Woo-Youl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 532 KB

Predictive significance of mean apparent

✍ Nagane, Motoo; Kobayashi, Keiichi; Tanaka, Masaki; Tsuchiya, Kazuhiro; Shishido- 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 702 KB

Chromosomal progression of malignant hum

✍ Sandra H. Bigner; Joachim Mark; Darell D. Bigner 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 756 KB

A case of progressive mucinous ovarian c

✍ Ira Winer; Ronald J. Buckanovich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 150 KB